Additionally, IGF2BP2 decreases MTA1 expression in the absence of FTO, indicating that FTO and IGF2BP2 control MTA1 expression in colorectal cancer via methylation [71]. The gene discussed is IGF2BP2; the disease is colorectal cancer.